Tag: entrepreneurs
-
Patent Office Decides for Broad and Editas in Crispr Case
The U.S. Patent and Trademark Office decided that the gene editing processes developed by Broad Institute and licensed to Editas Medicine do not interfere with techniques for genome editing created by University of California at Berkeley.
-
Tissue Regeneration Start-Up Gains $33M in Early Funds
A new enterprise founded by researchers at Stanford University aims to discover and develop drugs that repair and regenerate tissue from stem cells.
-
Ford Investing $1B in Artificial Intelligence Start-Up
Ford Motor Company is investing $1 billion in a start-up enterprise that applies artificial intelligence to the operation and management of autonomous vehicles.
-
Trial Testing Artificial Pancreas for Type 1 Diabetes
A clinical trial testing day-to-day use of a smartphone-controlled artificial pancreas for people with type 1 diabetes began enrolling participants.
-
Stomach Acid Harnessed to Power Ingestible Devices
Researchers at MIT and Harvard University designed a tiny device that in tests with animals show it can run for days powered by acids in the stomach.
-
Companies Recognized for Patient Safety Innovations
Three companies received awards for their products aimed at reducing the number of preventable deaths occurring in American hospitals.
-
Univ. Spin-Off Offering Pediatric Care Software
A company spun-off from Indiana University is marketing software written in its medical school to relate pediatric clinical guidelines to parents’ concerns during office visits.
-
EU Project to Develop More Versatile Heart Pacemakers
An initiative in Europe plans to design a new type of pacemaker device that adapts to a host of signals in the cardiovascular system and regulates multiple heart functions.
-
Immunotherapy Biotech Raises $102 Million in IPO
A biotechnology company developing treatments for solid tumors, harnessing the body’s immune system, for cancer patients most likely to respond is raising $102 million in its initial public stock offering.
-
Simpler Lab Cell Production Techniques Devised
A process is being developed that makes it easier to produce healthy and diseased cells in the lab from human specimens for regenerative medicine and research.